American Century Companies Inc. Boosts Position in Masimo Corporation $MASI

Key Points

• American Century Companies increased its stake in Masimo by 10.6% in Q3 to 168,341 shares (adding 16,113 shares), worth about $24.84 million and representing roughly 0.31% of the company.
• Other big moves include Viking Global's new ~$129 million position and large increases from Westfield, MFS and Ameriprise, with institutional/hedge fund ownership at about 85.96% of the float.
• Analyst sentiment is mostly cautious—Masimo has a consensus rating of Hold with a $181.17 target (1 Buy, 7 Holds, 1 Sell), and several firms recently downgraded the stock.

American Century Companies Inc. raised its holdings in shares of Masimo Corporation (NASDAQ:MASI - Free Report) by 10.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 168,341 shares of the medical equipment provider's stock after acquiring an additional 16,113 shares during the period. American Century Companies Inc. owned approximately 0.31% of Masimo worth $24,839,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the business. Viking Global Investors LP acquired a new position in Masimo during the second quarter valued at $129,096,000. Westfield Capital Management Co. LP grew its position in Masimo by 75.9% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,181,203 shares of the medical equipment provider's stock worth $198,702,000 after purchasing an additional 509,724 shares during the period. Massachusetts Financial Services Co. MA raised its stake in shares of Masimo by 25.5% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 2,470,393 shares of the medical equipment provider's stock valued at $415,570,000 after buying an additional 502,555 shares during the last quarter. Grantham Mayo Van Otterloo & Co. LLC acquired a new position in shares of Masimo in the 2nd quarter valued at about $40,468,000. Finally, Ameriprise Financial Inc. lifted its holdings in shares of Masimo by 86.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 394,487 shares of the medical equipment provider's stock valued at $66,361,000 after buying an additional 182,701 shares during the period. 85.96% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently commented on MASI. Wolfe Research downgraded Masimo from a "strong-buy" rating to a "hold" rating in a research note on Thursday, February 19th. BTIG Research downgraded Masimo from a "buy" rating to a "neutral" rating in a report on Wednesday, February 18th. Bank of America began coverage on Masimo in a research report on Monday, November 17th. They issued a "neutral" rating and a $162.00 price objective on the stock. Wells Fargo & Company cut shares of Masimo from an "overweight" rating to an "equal weight" rating and dropped their price objective for the stock from $190.00 to $180.00 in a research note on Wednesday, February 18th. Finally, Weiss Ratings reaffirmed a "sell (d)" rating on shares of Masimo in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $181.17.

Masimo Price Performance

NASDAQ:MASI opened at $175.42 on Monday. The company has a quick ratio of 1.47, a current ratio of 2.49 and a debt-to-equity ratio of 0.72. Masimo Corporation has a 52 week low of $125.94 and a 52 week high of $176.81. The stock's 50-day moving average price is $147.24 and its 200-day moving average price is $144.82. The stock has a market capitalization of $9.42 billion, a PE ratio of -16.64, a price-to-earnings-growth ratio of 1.78 and a beta of 1.21.

About Masimo

Masimo NASDAQ: MASI is a global medical technology company specializing in noninvasive monitoring solutions. The company's flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo's portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.